OSAMA FRANCIS: Open Payments
NPI 1235844796 · HOLLAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 30 payments from 10 companies in 2025. Trend: 2023 $143 · 2024 $1,943 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $309 |
| AstraZeneca Pharmaceuticals LP | 4 | $199 |
| GlaxoSmithKline, LLC. | 1 | $92 |
| Novo Nordisk Inc | 4 | $70 |
| PFIZER INC. | 2 | $40 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: QULIPTA, FARXIGA, UBRELVY, AREXVY, Ozempic, BREZTRI, NURTEC ODT, MOUNJARO.
Industry payments across OH — which companies pay providers there.
